ArticleAnnals of hematology2022

Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.

Roswitha Lüftinger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.